{"id":"W4309070531","doi":"10.1371/journal.pone.0277706","title":"Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar","year":2022,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":true,"has_abstract":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"F. Hoffmann-La Roche","keywords":"Fatty liver; Steatosis; Internal medicine; Medicine; Gastroenterology; Placebo; Fibrosis; Type 2 diabetes; Diabetes mellitus; Insulin resistance; Type 2 Diabetes Mellitus; Endocrinology; Pathology; Disease; Insulin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":{"nature":"Retraction","reason":"Concerns/Issues about Data;Concerns/Issues about Results and/or Conclusions;Error in Analyses;Error in Data;Unreliable Results and/or Conclusions;","date":"12/19/2025 0:00","openalex_flagged":true},"screen":null}